Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH)
Status:
Terminated
Trial end date:
2020-04-06
Target enrollment:
Participant gender:
Summary
The purpose of the study was to assess the effects of different doses of tropifexor (LJN452)
with respect to safety, tolerability, and on markers of liver inflammation in patients with
NASH